Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Shenzhen Kingsun Science & Technology Co.,Ltd (300235.SZ)
Shenzhen, CN
Headquartered in Shenzhen, China, Shenzhen Kingsun Science & Technology Co.,Ltd specializes in delivering educational products and services. The company's operations span the full lifecycle from research and development to sales and support, catering to primary and secondary schools, their teachers, and students throughout China. Among its key offerings are an intelligent teaching cloud platform, the "Golden Sun" educational software, and diverse online learning courses, in addition to other related services. The company was established in 1993.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.34% | +1.22% | -5.61% | -6.99% | -19.93% | -18.45% | +27.76% | -7.83% | +74.31% | -3.69% | +153.33% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Software - Application: +13.0%-1.4% Q1'26: -20.6% (vs Q1'25)
-
EPS growth Software - Application: +28.6%+5.9% Q1'26: -66.7% (vs Q1'25)
-
FCF margin FCF growth · Software - Application: +45.3%+29.7% Q1'26: +121.7% (vs Q1'25)
-
EBIT margin Software - Application: +9.4%+22.5% ★ Q1'26: +5.7% (vs Q1'25)
-
ROIC Software - Application: +7.5%+5.3% Q1'26: +1.3% (vs Q1'25)
-
Share dilution Software - Application: +0.0%+1.0% Q1'26: -4.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Software - Application: -1.16×0.00× ★ Q1'26: 0.00× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2019 actual |
|---|---|
| Revenue |
109.01M
est: 385.00M (-71.7%)
|
| EBITDA |
41.85M
est: 126.55M (-66.9%)
|
| EBIT |
36.32M
est: 107.80M (-66.3%)
|
| Net Income |
32.19M
|
| SGA |
35.37M
est: 84.10M (-57.9%)
|
| EPS |
0.13
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-28 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-27 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-26 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-25 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-22 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-21 | C+ | 2/5 | 3/5 | 3/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-20 | C+ | 2/5 | 3/5 | 3/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-19 | C+ | 2/5 | 3/5 | 3/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-18 | C+ | 2/5 | 3/5 | 3/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-15 | C+ | 2/5 | 3/5 | 3/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-14 | C+ | 2/5 | 3/5 | 3/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-13 | C+ | 2/5 | 3/5 | 3/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-12 | C+ | 2/5 | 3/5 | 3/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-11 | C+ | 2/5 | 3/5 | 3/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-08 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-07 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-06 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-30 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-29 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-28 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-27 | C | 2/5 | 2/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | C | 2/5 | 2/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | C | 2/5 | 2/5 | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 2/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | C | 2/5 | 2/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | C | 2/5 | 2/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | C | 2/5 | 2/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | C | 2/5 | 2/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-15 | C | 2/5 | 2/5 | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Feng Li | Vice GM & Secretary of the Board | — | female |
| Lin Ying He | Deputy GM & Chief Financial Officer | — | female |
| Qing Hua Lu | Deputy GM & Technical Director | — | male |
| Qiuping Shang | Accounting Supervisor | — | — |
| Wen Kai Zhang | GM, MD & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 300235.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
